Zobrazeno 1 - 10
of 387
pro vyhledávání: '"Jenny Heathcote"'
Publikováno v:
Canadian Journal of Gastroenterology, Vol 26, Iss 9, Pp 597-602 (2012)
BACKGROUND: Chronic hepatitis B (CHB) infection is endemic in East Asia, and those who emigrate to North America have higher rates of CHB infection when compared with the general population. To date, Chinese persons residing in Canada have not been m
Externí odkaz:
https://doaj.org/article/a372e3f4ee764ce488df960b11b4a17d
Publikováno v:
Canadian Journal of Gastroenterology, Vol 23, Iss 1, Pp 31-36 (2009)
BACKGROUND: Despite the availability of screening for chronic hepatitis B (CHB) infection and effective treatments now available, many at-risk individuals fail to seek appropriate medical attention.
Externí odkaz:
https://doaj.org/article/a0a4ad3b2d4a4b5499d469ea2cc8b3c1
Publikováno v:
Canadian Journal of Gastroenterology, Vol 20, Iss 2, Pp 107-111 (2006)
INTRODUCTION: In the past, antiviral therapy has been given to 15% to 30% of patients infected with hepatitis C virus (HCV). The efficacy of therapy has recently improved with the addition of ribavirin and pegylated interferon. The aim of the present
Externí odkaz:
https://doaj.org/article/51ff6fafd05f47d281f2f73c5b2017fe
Autor:
Morris Sherman, Lawrence Cohen, Mary Anne Cooper, Magdy Elkashab, Victor Feinman, David Fletcher, Nigel Girgrah, Jenny Heathcote, Mark Levstik, William B McNaull, David Wong, Florence Wong, Colina Yim
Publikováno v:
Canadian Journal of Gastroenterology, Vol 20, Iss 7, Pp 479-485 (2006)
Today, combination antiviral therapy with pegylated interferon-alpha and ribavirin (RBV) allows many patients infected with hepatitis C virus (HCV) to achieve a sustained virological response, which is equivalent to cure. Data also support the clinic
Externí odkaz:
https://doaj.org/article/d104cc8cf49a4d9b8ea2a3e3f5352f7a
Autor:
Jenny Heathcote
Publikováno v:
Canadian Journal of Gastroenterology, Vol 18, Iss 8, Pp 489-492 (2004)
The past 30 years have seen rapid growth in the number of clinical trials in liver disease; due mostly to effective drug discovery programs by the pharmaceutical industry. The advantages associated with therapeutic trials in chronic liver disease, or
Externí odkaz:
https://doaj.org/article/82e38746225d489a86a9572c86d6d711
Publikováno v:
Canadian Journal of Gastroenterology, Vol 17, Iss 3, Pp 183-186 (2003)
OBJECTIVE: To survey practising hepatologists about their attitudes and practices regarding interferon and ribavirin combination therapy for hepatitis C (HCV) patients in Canada.
Externí odkaz:
https://doaj.org/article/e8998f1ae4964e2dbaa2665b88e0656a
Publikováno v:
Canadian Journal of Gastroenterology, Vol 17, Iss 8, Pp 483-487 (2003)
BACKGROUND: Treatment of chronic hepatitis C virus (HCV) infection with interferon alpha-2b and ribavirin is costly in terms of side effects, medical resources and drug costs. Furthermore, less than 50% of patients overall have a sustained virologica
Externí odkaz:
https://doaj.org/article/9d8ec1150be14a4b9e2a92e675fd0219
Autor:
Jenny Heathcote
Publikováno v:
Canadian Journal of Gastroenterology, Vol 14, Iss 1, Pp 43-48 (2000)
The diagnosis of primary biliary cirrhosis (PBC) is most often made in the asymptomatic phase, sometimes before the development of abnormal liver biochemistry. The antimitochondrial antibody remains the predominant hallmark, although not all patients
Externí odkaz:
https://doaj.org/article/4a647f837d904808b934312aa6e8c30b
Autor:
Piotr Milkiewicz, Jenny Heathcote
Publikováno v:
Canadian Journal of Gastroenterology, Vol 19, Iss 10, Pp 631-633 (2005)
An increased prevalence of X chromosome monosomy has recently been demonstrated in patients with primary biliary cirrhosis (PBC). Chronic cholestasis of unknown etiology is a common clinical feature in patients with Turner syndrome who reach the four
Externí odkaz:
https://doaj.org/article/e92ed711d23541e99368b8616c3663d7
Publikováno v:
Canadian Journal of Gastroenterology, Vol 9, Iss 2, Pp 81-84 (1995)
Corticosteroid therapy for acute alcoholic hepatitis has been demonstrated to enhance survival in patients who are encephalopathic, and who do not have renal failure or gastrointestinal bleeding. However, the complications of steroid therapy in such
Externí odkaz:
https://doaj.org/article/6b58b87007f840cfa18a8d50c4ced058